Lisapharma Appoints Dr Nicola Ottolina as New CEO

  • Lisapharma has appointed Dr Nicola Ottolina as its new Chief Executive Officer.
  • Ottolina brings extensive sector knowledge and a results-focused approach to lead the company’s next phase of growth.

Lisapharma has announced the appointment of Dr Nicola Ottolina as its new Chief Executive Officer. The company described the decision as a step to guide the organisation into a new period of growth and stability.

Dr Ottolina has built his career within the organisation, progressing through a range of roles and responsibilities. According to Lisapharma, his professional journey has been marked by determination and steady advancement to reach the company’s top leadership position.

The appointment highlights his deep understanding of the sector and a practical, results-oriented vision. These qualities are seen by the company as key assets in steering Lisapharma’s strategy and operations.

CDMO News Analysed

The latest CDMO investments, partnerships, and market intelligence.

Real-time news analysis

  • Full tracker of partnerships and strategic announcements.
  • Deal value of disclosed investment
  • Regional and modality trends

Fill out the form below for immediate access:

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.